Live Breaking News & Updates on Red Platform

Stay updated with breaking news from Red platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rubius Therapeutics posts $42.3M loss in Q1 - Providence Business News


Rubius Therapeutics posts $42.3M loss in Q1
RUBIUS THERAPEUTICS reported a $42.3 million loss in the first quarter of 2021.
CAMBRIDGE, Mass. – Rubius Therapeutics Inc. reported a $42.3 million loss in the first quarter of 2021, or 51 cents per diluted share, the company said Monday.
The clinical-stage biopharmaceutical company posted a $48.5 million loss in the first quarter one year prior, or 60 cents per diluted share. The company owns and operates a manufacturing facility in North Smithfield.
In the first quarter of 2021, the company incurred $27.7 million in research and development costs, a decline from $36.2 million one year prior, and $13.2 million in general and administrative costs, an increase from $12.7 million one year prior. ....

United Kingdom , Pabloj Cagnoni , Rubius Therapeutics Inc , Rubius Therapeutics , Red Platform , Click Here , ஒன்றுபட்டது கிஂக்டம் , கிளிக் செய்க இங்கே ,